Viridium begins pot capsule sales through Broken Coast
EFX LABORATORIES COMMENCES COMMERCIAL CAPSULE SALES THROUGH STRATEGIC PARTNERSHIP
Viridium Pacific Group Ltd.'s wholly owned subsidiary, EFX Laboratories Inc., has commenced medical two-piece capsule sales through its partnership with Broken Coast Cannabis Ltd., a wholly owned subsidiary of Aphria Inc., available to BCC medical clientele through its on-line sales portal.
Under the terms of the agreement between EFX and Aphria, the agreement enables EFX to provide commercial manufacturing services with a revenue-sharing structure on the medical two-piece capsule containing various THC (tetrahydrocannabinol) and CBD (cannabidiol) concentrations.
The first available product under the partnership structure is a five-milligram THC capsule using a custom blend of BCC high-quality THC strains. This product offering gives medical clients a dose-controlled, predictive, tasteless, odourless and discreet option of consuming cannabis oil. Additionally, the whole-flower, full-spectrum capsule is one of the only available in the Canadian cannabis market resulting in a unique selling position. Commercial production is now under way and the product is available on Broken Coast and Aphria's website for their registered patients to purchase.
The realization of a commercial medical pill is a significant milestone for EFX and a step toward our vision to provide the market value-added products
stated Jay Garnett, Viridium's chief executive officer.
About Viridium Pacific Group Ltd.
Viridium is the parent company of Experion Biotechologies Inc., a Health Canada-licensed cultivation and processor of cannabis, based in Mission, B.C., and EFX, a medical products production and clinical research company based out of Calgary, Alta.
Viridium is invested in a portfolio of products, including a full spectrum of consumer needs, including products for adult use, wellness and therapeutic daily use.
© 2019 Canjex Publishing Ltd. All rights reserved.